Oncology & Hematology

Cancer prevention, screening, therapies, survivorship, and blood disorders.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Oncology & Hematology


intelligencer.ca > news > spin-for-the-cure-helps-fight-blood-cancers

Spin For The Cure helps fight blood cancers

3+ hour, 41+ min ago   (234+ words) Thirty-six riders took part in this fundraising event hosted by Light The Night Belleville, Quinte West and Prince Edward County in support of The Leukemia and Lymphoma Society of Canada. This year’s 3rd Annual Spin For The Cure event was held…...


insideprecisionmedicine.com > topics > oncology > ai-tool-outperforms-pd-l1-for-predicting-lung-cancer-immunotherapy-outcomes

AI Tool Outperforms PD-L1 for Predicting Lung Cancer Immunotherapy Outcomes

4+ hour, 38+ min ago   (253+ words) One of the study’s most notable findings was that relatively simple information already routinely collected in clinical practice carried substantial predictive power. Models using clinical and blood data, including PD-L1 expression, ECOG performance status, smoking status, metastatic sites, neutrophil-to-lymphocyte ratio,…...


reviewofoptometry.com > article > satralizumab-shows-clinically-meaningful-improvements-in-ted

Satralizumab Shows Clinically Meaningful Improvements in TED

8+ min ago   (202+ words) Adults aged 18 and older with either active, moderate to severe TED or inactive TED were included. Participants were randomized 1:1 to receive subcutaneous satralizumab or placebo. Dosing included a loading period at weeks zero, two and four, followed by every-four-week dosing....


minichart.com.sg > 09/14/2026 > biofrontera-wins-fda-approval-for-ameluz-in-superficial-basal-cell-carcinoma

Biofrontera Wins FDA Approval for Ameluz in Superficial Basal Cell Carcinoma

6+ hour, 25+ min ago   (296+ words) Minichart We value your privacy No cookies to display. Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Advertisement cookies are used to provide visitors with…...


oncodaily.com > voices > wafik-el-deiry-586125

Wafik El-Deiry: The 2026 WIN Symposium Comes to Rhode Island

2+ hour, 49+ min ago   (122+ words) Wafik El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared on LinkedIn: “Excited and looking forward to the 2026 WIN Symposium in Providence, Rhode Island, October 2-3, 2026. Register and submit an…...


thenewlede.org > 2026 > 09 > judge-weighs-fairness-of-7-25-billion-roundup-settlement-for-cancer-victims

Judge weighs "fairness" of $7.25 billion Roundup settlement for cancer victims

1+ hour, 33+ min ago   (972+ words) Opposing teams of attorneys spent hours on Monday battling over a proposed $7.25 billion settlement of the US Roundup cancer litigation that, if approved, would allow Bayer to keep selling its controversial glyphosate weed killers while providing roughly $10,000 to $165,000 for individuals…...


jerseyeveningpost.com > pride-of-jersey > 09/14/2026 > marie-haynes-angel-of-the-year

Marie Haynes - Angel of the Year

1+ hour, 51+ min ago   (160+ words) Nominated by: Ana Bexiga A WARD manager has been nominated for the Angel of the Year award, after being described by her nominator as the “best manager in the Hospital”. Marie Haynes, who is the manager for the Bartlett Ward,…...


servier.com > en > newsroom > cure51-research-partnership-glioblastoma

Servier and Cure51 launch a research partnership

7+ hour, 22+ min ago   (187+ words) While the prognosis remains extremely unfavorable for most patients, some outliers survive more than five years and are systematically identified through CURE51’s network of more than 150 oncology centers across 38 countries. Cure51 extracts and validates the biological mechanisms that underpin long-term survival,…...


uc.edu > news > articles > 2026 > 08 > a-legacy-of-care.html

A legacy of care

13+ min ago   (270+ words) On the other hand, Emmert was the keeper of a different tradition. Next spring, she will become the fifth member of her immediate family to earn both undergraduate and advanced degrees at UC. “I’m from a long line of Bearcats,…...


tradingview.com > news > urn:summary_document_transcript:quartr.com:4167805:0-alxo-lead-assets-advance-toward-phase-iii-with-strong-biomarker-focus-and-robust-financial-runway

ALXO: Lead assets advance toward phase III, with strong biomarker focus and robust financial runway

2+ hour, 9+ min ago   (71+ words) TradingView ALXO: Lead assets advance toward phase III, with strong biomarker focus and robust financial runway Two lead programs are advancing toward pivotal studies, with evorpacept showing strong biomarker-driven efficacy and ALX2004 progressing through dose escalation in multiple tumor types. Financial…...